Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C(2025) First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer J Nucl Med, 66(5), 732-738 DOI 10.2967/jnumed.124.269299, PubMed 40081958
Fauske L, Bruland Ø, Hompland I(2025) Addressing and supporting the unmet needs of sarcoma survivors: a qualitative study Int J Qual Stud Health Well-being, 20(1), 2597584 DOI 10.1080/17482631.2025.2597584, PubMed 41382317
Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging, 52(13), 4847-4859 DOI 10.1007/s00259-025-07330-y, PubMed 40397137
